Lip-Bu Tan Joins 4baseCare Advisory Board to Drive Genomics Innovation

Lip-Bu Tan, a prominent venture capitalist and tech industry leader, joins the advisory board of 4baseCare. With over thirty years of experience in deep tech venture capital and a significant influence in healthcare, Tan aims to support 4baseCare's mission to revolutionize cancer treatment through advanced genomics and digital health solutions.

Lip-Bu Tan, a highly influential figure in the tech and healthcare sectors, has joined the advisory board of 4baseCare, an Illumina Accelerator Company specializing in precision oncology solutions. Tan brings over three decades of deep tech venture capital expertise, enhancing 4baseCare's mission to revolutionize cancer treatment through genomics and digital health innovations.

In addition to his roles at Walden International and Walden Catalyst Ventures, Tan serves as an advisor to Yali Capital and holds leadership positions in several healthcare companies. His extensive experience and strategic insights are expected to drive 4baseCare's growth and expansion into new markets.

4baseCare plans to set up new genomics laboratories in the Philippines, Nepal, and Dubai, focusing on data analytics, clinical insights, and data-driven treatment recommendations. Founded in 2018, 4baseCare is committed to providing targeted cancer therapies tailored to specific genetic profiles, addressing a critical gap in cancer treatment across Asia and the Middle East.

(With inputs from agencies.)